Biodesix Stock Quote BDSX - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.72

Bid

1.67

Ask

1.73

Volume

58,941

1.675 Day's Range 1.73

1.03 52 Week Range 2.21

Market Cap

197.26M

Previous Close

1.66

Open

1.73

Last Trade

1.73

Last Trade Time

Financial Volume

$ 100,591

VWAP

1.7066

Average Volume (3m)

165,322

Shares Outstanding

114,685,783

Dividend Yield

PE Ratio

-3.76

Earnings Per Share (EPS)

-0.45

Revenue

49.09M

Net Profit

-52.15M

Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic researc... Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics. Show more

Sector

Medical Laboratories

Industry

Medical Laboratories

Website

www.biodesix.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Biodesix Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker BDSX. The last closing price for Biodesix was $1.66. Over the last year, Biodesix shares have traded in a share price range of $ 1.03 to $ 2.21.

Biodesix currently has 114,685,783 shares outstanding. The market capitalization of Biodesix is $190.38 million. Biodesix has a price to earnings ratio (PE ratio) of -3.76.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.08	-4.44444444444	1.8	1.8	1.62	45537	1.65902812	CS
4	0.2	13.1578947368	1.52	1.83	1.48	159272	1.59024333	CS
12	0.39	29.3233082707	1.33	1.83	1.2	165322	1.57241118	CS
26	-0.23	-11.7948717949	1.95	2.21	1.15	145836	1.52455989	CS
52	0.62	56.3636363636	1.1	2.21	1.03	118209	1.58872437	CS
156	-8.13	-82.538071066	9.85	10.22	0.955	167789	2.38787974	CS
260	-11.87	-87.3436350258	13.59	31.99	0.955	163011	4.87452524	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	259.77k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.45M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M